Who are in the management team of Natural Biocon?

As of March 2023, the management team of Natural Biocon includes Arunkumar D Prajapati (Chairman/Executive Director), Manish Patel (Executive Director & CFO), and three Independent Non-Executive Directors: Darshangi Patel, Suryakant Govind Lohar, and Bhaskar Waman Vishe. They oversee the company's operations and strategic direction.

As of March 2023, the management team of Natural Biocon includes the following individuals:<BR><BR>1. Arunkumar D Prajapati - Chairman / Executive Director<BR>2. Manish Patel - Executive Director & CFO<BR>3. Darshangi Patel - Independent Non-Executive Director<BR>4. Suryakant Govind Lohar - Independent Non-Executive Director<BR>5. Bhaskar Waman Vishe - Independent Non-Executive Director<BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

Has Natural Biocon declared dividend?

No Dividend History Available

Who are the peers of the Natural Biocon?

Natural Biocon's peers include P I Industries, UPL, Bayer CropSci., and others, with varying management risks and growth rates. Sharda Cropchem leads in 1-year returns at 102.43%, while Natural Biocon's return is -5.03%.

Peers: The peers of Natural Biocon are P I Industries, UPL, Bayer CropSci., Sumitomo Chemi., Dhanuka Agritech, Sharda Cropchem, Rallis India, Bhagiradha Chem., Adarsh Plant, Phyto Chem (I).<BR><BR>Quality Snapshot: Excellent management risk is observed at Bayer CropSci., Dhanuka Agritech, and the rest. Good management risk is found at P I Industries, Sumitomo Chemi., Sharda Cropchem, and the rest. Average management risk is present at UPL, Rallis India, and Bhagiradha Chem., while Below Average management risk is noted at Adarsh Plant and Phyto Chem (I). Growth is excellent at P I Industries, while below average growth is seen at UPL, Bayer CropSci., Sumitomo Chemi., Dhanuka Agritech, Sharda Cropchem, Rallis India, Bhagiradha Chem., Adarsh Plant, and Phyto Chem (I). Capital structure is excellent at P I Industries, Bayer CropSci., Sumitomo Chemi., Dhanuka Agritech, Sharda Cropchem, Rallis India, while good capital structure is noted at Bhagiradha Chem., and below average at UPL, Adarsh Plant, and Phyto Chem (I).<BR><BR>Return Snapshot: Sharda Cropchem has the highest 1-year return at 102.43%, while Adarsh Plant has the lowest at -10.98%. Natural Biocon's 1-year return is -5.03%, which is higher than Adarsh Plant's but lower than all other peers. Additionally, peers with negative six-month returns include Natural Biocon, Adarsh Plant, and Phyto Chem (I).

What is the technical trend for Natural Biocon?

As of June 3, 2025, Natural Biocon's technical trend is mildly bearish, indicated by bearish weekly MACD, mildly bearish moving averages, and mixed signals from Bollinger Bands and KST.

As of 3 June 2025, the technical trend for Natural Biocon has changed from bearish to mildly bearish. The weekly MACD remains bearish, while the monthly MACD is mildly bearish, indicating a lack of strong upward momentum. The daily moving averages also reflect a mildly bearish stance. The Bollinger Bands show bullish signals on both weekly and monthly time frames, suggesting potential price support. However, the KST indicates bearish momentum on the weekly chart and bullish on the monthly, creating mixed signals. Dow Theory shows a mildly bullish stance on the weekly but mildly bearish on the monthly, further contributing to the overall mildly bearish outlook. The RSI shows no signals in both time frames. Overall, the current technical stance is mildly bearish, with key indicators being the bearish MACD and mildly bearish moving averages.

What does Natural Biocon do?

Natural Biocon (India) Ltd operates in the chemicals and natural extracts sector within the Pesticides & Agrochemicals industry, reporting net sales of 14 Cr and a net loss of 5 Cr for the quarter ending March 2025, with a market cap of INR 31 Cr. The company has no debt and offers no dividends.

Overview: <BR>Natural Biocon (India) Ltd is engaged in the business of chemicals, natural extracts, and agricultural produces within the Pesticides & Agrochemicals industry, categorized as a Micro Cap company.<BR><BR>History: <BR>Natural Biocon (India) Ltd was incorporated as a Public Limited Company in 1992 and obtained its Certificate of Commencement of Business shortly thereafter. The latest quarterly results reported net sales and profit for the period ending March 2025.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 14 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -5 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: INR 31 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>Industry P/E: 32 <BR>Dividend Yield: 0.00% <BR>Debt Equity: 0.00 <BR>Return on Equity: 0.00% <BR>Price to Book: 0.00 <BR><BR>Contact Details: <BR>No Company Details Available <BR>Registrar Address: Not available.

Who are the top shareholders of the Natural Biocon?

The top shareholders of Natural Biocon include Gitaben Sureshbhai Shah, the largest promoter with 3.3%, and Aventez Media & Technologies Limited, the largest public shareholder with 9.7%. Individual investors collectively hold 33.35% of the shares, with no institutional holdings reported.

The top shareholders of Natural Biocon include Gitaben Sureshbhai Shah, who is the promoter with the highest holding at 3.3%. The highest public shareholder is Aventez Media & Technologies Limited, holding 9.7%. Additionally, individual investors collectively hold 33.35% of the company's shares. There are no institutional holdings from mutual funds or foreign institutional investors.

How big is Natural Biocon?

As of 24th July, Natural Biocon (India) Ltd has a market capitalization of 31.00 Cr, with recent net sales of 8.36 Cr and a net profit of 0.06 Cr. The company reported shareholder's funds of 12.38 Cr and total assets of 16.77 Cr for the annual period ending March 2024.

As of 24th July, Natural Biocon (India) Ltd has a market capitalization of 31.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Natural Biocon reported Net Sales of 8.36 Cr and a Net Profit of 0.06 Cr.<BR><BR>For the latest annual period ending March 2024, the company had Shareholder's Funds amounting to 12.38 Cr and Total Assets of 16.77 Cr.

Why is Natural Biocon falling/rising?

As of N/A, Natural Biocon (India) Ltd's stock price is currently 5.90, reflecting a 3.59% decline. The stock has dropped 23.77% over the past month and 54.65% year-to-date, underperforming significantly compared to the Sensex, which has gained 3.93% this year.

As of N/A, Natural Biocon (India) Ltd is experiencing a decline in its stock price, currently at 5.90, which reflects a decrease of 0.22 or 3.59%. Unfortunately, the data for today's price summary is not available, which limits the analysis of immediate factors affecting the stock. Over the past month, the stock has seen a significant drop of 23.77%, while year-to-date, it has plummeted by 54.65%. In contrast, the stock's performance over the past year shows a decline of 51.16%, indicating a persistent downward trend without any positive factors reported to counterbalance these losses.<BR><BR>In the broader market context, the stock's short-term performance does not align favorably with the benchmark, as the Sensex has gained 0.97% over the past week, while Natural Biocon has remained flat. This disparity highlights the stock's underperformance relative to the market. Additionally, the year-to-date performance shows a stark contrast, with the Sensex up by 3.93%, further emphasizing the challenges faced by Natural Biocon in attracting investor confidence amidst a generally positive market environment.

When is the next results date for Natural Biocon?

Natural Biocon will announce its results on 12 November 2025.

Natural Biocon will declare its results on 12 November 2025.

How has been the historical performance of Natural Biocon?

Natural Biocon's historical performance shows significant sales growth from zero in Mar'20 to 8.35 Cr in Mar'25, despite a decline from 13.53 Cr in Mar'24. The company faces challenges with profitability, as profits decreased while total assets and liabilities rose significantly.

Answer:<BR>The historical performance of Natural Biocon shows a fluctuating trend in its financial metrics over the years.<BR><BR>Breakdown:<BR>Natural Biocon's net sales have seen significant growth from Mar'20, where it reported no sales, to Mar'25 with sales of 8.35 Cr, although this is a decline from the previous year's sales of 13.53 Cr. The total operating income followed a similar pattern, increasing from 0.00 Cr in Mar'20 to 8.35 Cr in Mar'25, but also down from 13.53 Cr in Mar'24. The company's total expenditure, excluding depreciation, rose from 0.03 Cr in Mar'20 to 8.29 Cr in Mar'25, reflecting increased operational costs. Operating profit (PBDIT) peaked at 0.24 Cr in Mar'23 but fell to 0.06 Cr in Mar'25. Profit before tax also decreased from 0.25 Cr in Mar'23 to 0.06 Cr in Mar'25, while profit after tax dropped to 0.04 Cr in Mar'25 from 0.15 Cr in Mar'24. The company's equity capital increased significantly to 25.78 Cr in Mar'25 from 11.37 Cr in Mar'24, and total assets rose to 38.52 Cr in Mar'25 from 16.77 Cr in Mar'24. However, total liabilities also increased, reaching 38.52 Cr in Mar'25. The cash flow from operating activities was positive at 1.00 Cr in Mar'25, while cash flow from investing activities was negative at -21.00 Cr, indicating significant investments. Overall, Natural Biocon's financial performance reflects both growth and challenges in profitability and operational efficiency over the years.

Which are the latest news on Natural Biocon?